Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
Gervin, Maurice
and
Barnes, Thomas R.E.
2000.
Assessment of drug-related movement disorders in schizophrenia.
Advances in Psychiatric Treatment,
Vol. 6,
Issue. 5,
p.
332.
Owens, D. G. C.
2000.
Commentary.
Advances in Psychiatric Treatment,
Vol. 6,
Issue. 5,
p.
341.
Kerwin, Robert W
Mancama, Dalu T
and
Arranz, Maria J
2001.
Genetic strategies for the personalization of antipsychotic treatment.
Expert Review of Molecular Diagnostics,
Vol. 1,
Issue. 3,
p.
275.
Kim, Jong‐Hoon
Jung, Hee Yeon
Kang, Ung Gu
Jeong, Seong Hoon
Ahn, Yong Min
Byun, Hee‐Jung
Ha, Kyoo‐Seob
and
Kim, Yong Sik
2002.
Metric characteristics of the drug‐induced extrapyramidal symptoms scale (DIEPSS): A practical combined rating scale for drug‐induced movement disorders.
Movement Disorders,
Vol. 17,
Issue. 6,
p.
1354.
Zhang, ZhiJun
Zhang, XiaoBin
Hou, Gang
Sha, WeiWei
and
Reynolds, Gavin P
2002.
The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism.
Journal of Psychiatric Research,
Vol. 36,
Issue. 5,
p.
317.
Jordan, Sue
2002.
Managing adverse drug reactions: an orphan task.
Journal of Advanced Nursing,
Vol. 38,
Issue. 5,
p.
437.
Barnes, Thomas R. E.
2003.
The Barnes Akathisia Rating Scale–Revisited.
Journal of Psychopharmacology,
Vol. 17,
Issue. 4,
p.
365.
Mattay, V.S.
and
Casey, D.E.
2003.
Schizophrenia.
p.
552.
Arranz, M.J.
and
Kerwin, R.W.
2003.
Pharmacogenetic and pharmacogenomic research for the prediction of response to antipsychotics in schizophrenia.
Drug Development Research,
Vol. 60,
Issue. 2,
p.
104.
2004.
Drug-Induced Movement Disorders.
Vol. 20045530,
Issue. ,
Reynolds, Gavin P.
2004.
Receptor Mechanisms in the treatment of Schizophrenia.
Journal of Psychopharmacology,
Vol. 18,
Issue. 3,
p.
340.
BOZIKAS, VASILIS P.
KOSMIDIS, MARY H.
ANEZOULAKI, DIMITRA
GIANNAKOU, MARIA
and
KARAVATOS, ATHANASIOS
2004.
Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia.
Journal of the International Neuropsychological Society,
Vol. 10,
Issue. 4,
p.
549.
Jordan, S.
Knight, J.
and
Pointon, D.
2004.
Monitoring adverse drug reactions: scales, profiles, and checklists.
International Nursing Review,
Vol. 51,
Issue. 4,
p.
208.
Kim, Jong‐Hoon
Jin, Young‐Ho
Kang, Ung Gu
Ahn, Yong Min
Ha, Kyoo‐Seob
and
Kim, Yong Sik
2005.
Neuroleptic‐induced acute and chronic akathisia: A clinical comparison.
Movement Disorders,
Vol. 20,
Issue. 12,
p.
1667.
Jung, Hee-Yeon
Kim, Jong-Hoon
Ahn, Yong-Min
Kim, Seong-Chan
Hwang, Samuel S.
and
Kim, Yong-Sik
2005.
Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) as a subjective measure of drug-induced parkinsonism and akathisia.
Human Psychopharmacology: Clinical and Experimental,
Vol. 20,
Issue. 1,
p.
41.
Mazurek, Michael F.
and
Rosebush, Patricia I.
2005.
Drug Induced Movement Disorders.
p.
72.
Arranz, Maria
Mancama, Dalu
and
Kerwin, Robert
2006.
Pharmacogenetics.
p.
295.
Abe, Kazuhiko
2006.
Psychiatric symptoms associated with oculogyric crisis: A review of literature for the characterization of antipsychotic-induced episodes.
The World Journal of Biological Psychiatry,
Vol. 7,
Issue. 2,
p.
70.
Owens, David Cunningham
2008.
How CATIE brought us back to Kansas: a critical re-evaluation of
the concept of atypical antipsychotics and their place in the treatment of
schizophrenia.
Advances in Psychiatric Treatment,
Vol. 14,
Issue. 1,
p.
17.
Chadwick, Howard
and
Bressington, Dan
2009.
Medicines Management in Mental Health Care.
p.
23.